Predictors of failed closure of patent ductus arteriosus with indomethacin

Singapore Medical Journal

Volumn 47, Issue 9, 2006, Pages 763-768

  Boo, Nem Yun ^a,b   Mohd Amin, I ^a   Bilkis, A A ^a   Yong Junina, F ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Indomethacin therapy; Patent ductus arteriosus; Preterm infants

Indexed keywords

INDOMETACIN;

AORTA; ARTICLE; BIRTH WEIGHT; BODY WEIGHT; CONTROLLED STUDY; DRUG DOSE REGIMEN; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HEART LEFT ATRIUM; HUMAN; INCIDENCE; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PATENT DUCTUS ARTERIOSUS; PREDICTION; PREMATURITY; THROMBOCYTE COUNT; TREATMENT FAILURE; TREATMENT RESPONSE; WOUND CLOSURE;

CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; EMPIRICAL RESEARCH; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; MALE; OBSERVATION; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT FAILURE;

EID: 33748607701     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 1979; 95:865-6.
2. Alverson DC, Eldridge MW, Johnson JD, et al. Effect of patent ductus arteriosus on left ventricular output in premature infants. J Pediatr 1983; 102:754-7.
3. Gittenberger-de-Groot AC, Van Ertbruggen I, Moulaert AJ, Harinck E. The ductus arteriosus in the preterm infant: histologic and clinical observation. J Pediatr 1980; 96:88-93.
4. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 1976; 295:526-9.
5. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295:530-3.
6. Couser RJ, Schilling CG, Ferrara TB, et al. Relationship of serum indomethacin levels to ductus arteriosus closure in extremely premature infants treated with prophylactic indomethacin. Pediatric Res 1996; 39 Suppl 2:203.
7. Van Overmeire B, Van de Broek H, Van Laer P, Weyler J, Vanhaesebrouck P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 2001; 138:205-11.
8. Comment in: J Pediatr 2002; 140:487-9.
9. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995; 127:774-9.
10. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effect of indomethacin in premature infants with patent ductus arteriosus: result of national collaborative study. J Pediatr 1983; 102:895-905.
11. Firth J, Pickering D. Timing of indomethacin therapy in persistent ductus. Lancet 1980; 2:144.
12. Narayanan M, Cooper B, Weiss H, Clyman RI. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr 2000; 136:330-7.
13. Goldstein MR, Longtin CM, Martin GI, et al. Early surgical closure of the patent ductus arteriosus (PDA) in the low birth weight neonate without primary indomethacin prophylaxis or treatment. Pediatr Res 1998; 43:S282.
14. Hornblad PY. Studies on closure of ductus arteriosus. III. Species differences in closure rate and morphology. Cardiologia 1967; 51:262-82.
15. Fowlie P, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002; (3):CD000174.
16. Evans DH, Levene MI, Archer LN. The effect of indomethacin on cerebral blood velocity in premature infants. Dev Med Child Neurol 1987; 29:776-82.